Drugs, Devices, and FDA

For several decades, the American Academy of Orthopaedic Surgeons (AAOS) has interacted with the Food and Drug Administration (FDA). To ensure that medical treatments reach patients in a timely manner, the AAOS closely follows FDA regulatory and legislative developments and provides appropriate responses to proposed rules, guidance documents, and legislative initiatives. The AAOS supports the approval and clearance of safe and effective medical products for musculoskeletal care. Additionally, with appropriate data, the AAOS encourages the downclassification of devices whose risk/benefit profile can be managed with the FDA's use of general and special controls, including the use of guidance documents and consensus standards.

Recent News

Position Statements

Important Resources

Comment/Congressional Letters

Other Materials